(Q33852473)

29 July 2017

1 reference

title

Optimization of gadolinium-based MRI contrast agents for high magnetic-field applications (English)

1 reference

magnetic resonance imaging

29 July 2017

1 reference

1 reference

0 references

author name string

Lothar Helm

series ordinal

1

1 reference

29 July 2017

publication date

1 March 2010

1 reference

Future Medicinal Chemistry

29 July 2017

published in

1 reference

29 July 2017

volume

2

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

385-396

1 reference

Ultrahigh field magnetic resonance imaging and spectroscopy

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

Whole-body MRI at high field: technical limits and clinical potential

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

9.4T human MRI: preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

The optimal use of contrast agents at high field MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

Classification and basic properties of contrast agents for magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

MR contrast agents, the old and the new.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

Targeting cells with MR imaging probes based on paramagnetic Gd(III) chelates

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

Polyamine-substituted gadolinium chelates: a new class of intracellular contrast agents for magnetic resonance imaging of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1 contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

Relaxation Processes in a System of Two Spins

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

Electronic relaxation of paramagnetic metal ions and NMR relaxivity in solution: critical analysis of various approaches and application to a Gd(III)-based contrast agent

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

Equilibrium and kinetic properties of the lanthanoids(III) and various divalent metal complexes of the heptadentate ligand AAZTA.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

Tuning the coordination number of hydroxypyridonate-based gadolinium complexes: implications for MRI contrast agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

Towards new functional nanostructures for medical imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

The detection limit of a Gd3+-based T1 agent is substantially reduced when targeted to a protein microdomain

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

Inorganic and bioinorganic solvent exchange mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

Towards the rational design of MRI contrast agents: electron spin relaxation is largely unaffected by the coordination geometry of gadolinium(III)-DOTA-type complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

Design of Gd(III)-based magnetic resonance imaging contrast agents: static and transient zero-field splitting contributions to the electronic relaxation and their impact on relaxivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

Multiple-frequency EPR spectra of two aqueous Gd3+ polyamino polypyridine carboxylate complexes: a study of high field effects

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

A multinuclear NMR relaxometry study of ternary adducts formed between heptadentate Gd(III) chelates and L-lactate

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

Physicochemical properties of the high-field MRI-relevant [Gd(DTTA-Me)(H2O)2]- complex

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

Substituent effects on Gd(III)-based MRI contrast agents: optimizing the stability and selectivity of the complex and the number of coordinated water molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

Gd-hydroxypyridinone (HOPO)-based high-relaxivity magnetic resonance imaging (MRI) contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

A highly stable gadolinium complex with a fast, associative mechanism of water exchange.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

Highly soluble tris-hydroxypyridonate Gd(III) complexes with increased hydration number, fast water exchange, slow electronic relaxation, and high relaxivity

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

A ruthenium-based metallostar: synthesis, sensitized luminescence and (1)H relaxivity

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

A starburst-shaped heterometallic compound incorporating six densely packed gd(3+) ions.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

First in vivo MRI assessment of a self-assembled metallostar compound endowed with a remarkable high field relaxivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

A benzene-core trinuclear GdIII complex: towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

In vivo MRI assessment of a novel GdIII-based contrast agent designed for high magnetic field applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

Strategies for increasing the sensitivity of gadolinium based MRI contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

Gadolinium chelate coated gold nanoparticles as contrast agents for both X-ray computed tomography and magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

Gold nanoparticles functionalised by Gd-complex of DTPA-bis(amide) conjugate of glutathione as an MRI contrast agent

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

Gold nanoparticles functionalized with gadolinium chelates as high-relaxivity MRI contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

Superparamagnetic gadonanotubes are high-performance MRI contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

NMR RELAXATION IN SOLUTION OF PARAMAGNETIC COMPLEXES: RECENT THEORETICAL PROGRESS FOR S≥1

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

Magnetic Resonance Visualization of Tumor Angiogenesis by Targeting Neural Cell Adhesion Molecules with the Highly Sensitive Gadolinium-Loaded Apoferritin Probe

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.174

21 January 2018

Identifiers

DOI

10.4155/FMC.09.174

1 reference

29 July 2017

1 reference